G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28 | -95.8% | 19,366 | -92.7% | 0.00% | -97.0% |
Q2 2023 | $662 | -99.5% | 266,017 | +2309.1% | 0.07% | +266.7% |
Q3 2022 | $138,000 | -86.3% | 11,042 | -94.6% | 0.02% | -88.1% |
Q2 2022 | $1,006,000 | +143.6% | 203,545 | +469.5% | 0.15% | +118.8% |
Q3 2020 | $413,000 | +47.5% | 35,742 | +40.6% | 0.07% | -1.4% |
Q1 2020 | $280,000 | – | 25,428 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
Birchview Capital, LP | 40,000 | $217 | 0.15% |
XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |